Printer Friendly

CNS ANNOUNCES CLOSING OF OFFERING OF COMMON SHARES

 CNS ANNOUNCES CLOSING OF OFFERING OF COMMON SHARES
 MINNEAPOLIS, April 16 /PRNewswire/ -- CNS, Inc. (NASDAQ-NMS: CNXS)


announced today the closing of the public offering of 1,200,000 shares of its $.01 par value common stock through Summit Investment Corporation, a Minneapolis-based underwriter.
 The shares were sold to the public at $2.375 per share, with the net proceeds of approximately $2,390,000 to be used to increase working capital and to continue to develop, test and market present and future products. The underwriter has an over-allotment option to acquire an additional 180,000 shares.
 All of the company's outstanding preferred stock was converted to common stock upon conclusion of the offering and the company now has 6,373,040 shares of common stock outstanding.
 CNS designs, manufactures and markets computer-based medical diagnostic devices used principally to test for sleep related disorders such as sleep apnea, insomnia and narcolepsy.
 The company's common stock trades on the NASDAQ National Market System under the symbol "CNXS."
 -0- 4/16/92
 /CONTACT: Daniel E. Cohen, M.D., of CNS, 612-474-7600; or G. James Spinner of Summit Investment, 612-338-1407/
 (CNXS) CO: CNS, Inc. ST: Minnesota IN: CPR MTC SU: OFR


AL -- MN013 -- 9324 04/16/92 12:57 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 16, 1992
Words:206
Previous Article:GLACIER WATER REPORTS HIGHER SALES, PRETAX INCOME
Next Article:IBM ANNOUNCES PEN-BASED COMPUTING SOFTWARE DEVELOPERS ASSISTANCE PROGRAM, FIRST PEN-BASED COMPUTER


Related Articles
CNS REPORTS INTENT TO FILE REGISTRATION STATEMENT
CNS REPORTS FIRST QUARTER RESULTS
CNS, INC. TO FILE REGISTRATION STATEMENT
CNS, INC. TO OFFER COMMON STOCK
CNS, INC. SELLS COMMON STOCK AND IS APPROVED FOR QUOTATION ON THE NASDAQ NATIONAL MARKET
CNS, INC. ANNOUNCES SALE OF OVER-ALLOTMENT SHARES
CNS REPORTS ANNUAL EARNINGS
CNS, INC., ANNOUNCES PROPOSED SECONDARY STOCK OFFERING
CYTOTHERAPEUTICS ANNOUNCES PUBLIC OFFERING TOTALING $10.4 MILLION
CNS, INC., ADOPTS SHAREHOLDER RIGHTS PLAN

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters